1-4 of 4
Hyun Don Yun
Close
Sort by
Journal Articles

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality

Clinical Trials & Observations
Celalettin Ustun, Todd E. DeFor, Fatma K. Karadag, Hyun Don Yun, Sunita Nathan, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Shernan G. Holtan, Khalid Amin
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2317–2324.
https://doi.org/10.1182/bloodadvances.2020001793
Published: 2020
Journal Articles

Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3 - ITD –positive acute myeloid leukemia

Hyun Don Yun, Sunita Nathan, Melissa Larson, Mohammad J. Hussain, Deborah A. Katz, Ankur Varma, Ira Miller, Celalettin Ustun
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3709–3712.
https://doi.org/10.1182/bloodadvances.2019000775
Published: 2019
Journal Articles

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia

Hyun Don Yun, Dawn K. Schirm, Martin Felices, Jeffrey S. Miller, Craig E. Eckfeldt
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2448–2452.
https://doi.org/10.1182/bloodadvances.2019000064
Published: 2019
Journal Articles

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells

Hyun Don Yun, Martin Felices, Daniel A. Vallera, Peter Hinderlie, Sarah Cooley, Michel Arock, Jason Gotlib, Celalettin Ustun, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1580–1584.
https://doi.org/10.1182/bloodadvances.2018018176
Published: 2018
Includes: Supplemental data